Related Experiment Videos
Fibrin glue treatment for recurrent pneumothorax in a premature infant
J Kuint1, D Lubin, U Martinowitz
1Department of Neonatology, Tel Aviv University, Israel.
American Journal of Perinatology
|May 1, 1996
Insights
Recurrent pneumothorax in a premature infant was effectively managed using fibrin glue pleurodesis via chest tube. This innovative treatment proved both safe and successful for the infant.
Area of Science:
- Neonatal Medicine
- Thoracic Surgery
- Pulmonology
Background:
- Recurrent pneumothorax poses a significant challenge in premature infants, often requiring invasive interventions.
- Traditional treatments may carry risks or prove insufficient for persistent air leaks.
Observation:
- A case study involving a premature infant with recurrent pneumothorax is presented.
- The infant underwent treatment via the injection of fibrin glue into the pleural cavity through an existing chest tube.
Findings:
- The fibrin glue injection successfully achieved pleurodesis, resolving the recurrent pneumothorax.
- The procedure was demonstrated to be both safe and effective in this clinical scenario.
Implications:
- Fibrin glue pleurodesis offers a potentially valuable and minimally invasive therapeutic option for managing recurrent pneumothorax in neonates.
- This case highlights the feasibility and positive outcomes associated with this approach, warranting further investigation.
Abstract:
A case of a premature infant in whom recurrent pneumothorax was successfully treated by injection of fibrin glue into the pleural cavity through the chest tube is reported. Pleurodesis with fibrin glue was found to be both safe and effective.